Vaccine Resources

Park County COVID19 Vaccine Resources

In accordance with state guidance, Park County Public Health is offering the COVID19 vaccine to all eligible individuals: Pfizer for ages 12 years and  the Johnson & Johnson vaccines for people 18 and older. 

Upcoming Clinics:

  • Thursday, July 29 - Bailey – St. Mary of the Rockies, 236 Bulldogger Road Bailey CO 80421 | Every Thursday |   Noon – 6 PM Vaccine type: J&J vaccine 18+ and Pfizer 12+: Register for an appointment HERE!
  • Thursday, August 5 - Platte Canyon High School - 7:30 AM - 3:30 PM - Register for an appointment here.
  • Thursday, August 5 - St. Mary of the Rockies, 236 Bulldogger Road Bailey CO 80421 Noon – 6 PM Vaccine type: J&J vaccine 18+ and Pfizer 12+:- Register for an appointment here.
  • Thursday, August 12  - Platte Canyon High School - 7:30 AM - 3:30 PM - Register for an appointment here.
  • Thursday, August 12  - St. Mary of the Rockies, 236 Bulldogger Road Bailey CO 80421 Noon – 6 PM Vaccine type: J&J vaccine 18+ and Pfizer 12+: Register for an appointment here.
  • Thursday, August 19St. Mary of the Rockies, 236 Bulldogger Road Bailey CO 80421 Noon – 6 PM Vaccine type: J&J vaccine 18+ and Pfizer 12+: Register for an appointment here.

  • Thursday, August 26  – St. Mary of the Rockies, 236 Bulldogger Road Bailey CO 80421  Every Thursday |   Noon – 6 PM Vaccine type: J&J vaccine 18+ and Pfizer 12+:  Register for an appointment here.

  • Thursday, Sept. 2 St. Mary of the Rockies, 236 Bulldogger Road Bailey CO 80421  Every Thursday |   Noon – 6 PM Vaccine type: J&J vaccine 18+ and Pfizer 12+:  Register for an appointment here.

Vaccine Appointments Available (1) Opens in new window

Other Vaccine Clinic Resources and Options

The following information has been provided by each hospital system, facility, or provider regarding vaccine distribution plans and options for patients. Please visit their websites to learn more:

And visit www.cocovidvaccine.org for a complete listing of vaccine providers and sign-up links statewide.

Approved Vaccine Types 

Safety and Monitoring:

  • On July 13, the FDA published a press release and sent a fact sheet (here, here) to healthcare providers (i.e.doctors, nurses, hospitals, etc.) about a recent safety signal they detected: Guillain-Barre Syndrome (GBS). Based on an analysis of Vaccine Adverse Event Reporting (VAERS) data, the FDA found 100 reports of GBS following 12.5 million vaccines. Out of the 100 cases, 95% were serious and required hospitalization. One person died. 
  • On June 23, CDC issued a safety concern associated with Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination 
  • On April 23, the press release from the FDA and CDC, who determined the use of the Janssen COVID-19 Vaccine should be resumed in the United States and that the FDA and CDC have confidence that this vaccine is safe and effective in preventing COVID-19. CDPHE has decided to proceed by including FDA’s updated warning to patients about the increased risk of very rare but potentially severe TTS, particularly among women under the age of 50.

Overview of approved vaccines

  • The Johnson & Johnson and Moderna vaccines are authorized for ages 18 and older and the Pfizer vaccine is approved for 12 and older. Please check the clinic you are registering for carefully to ensure it is offering your preferred choice.
  • On May 10, the U.S. Food and Drug Administration expanded the emergency use authorization (EUA) for the Pfizer COVID-19 Vaccine for the prevention of COVID-19 to include adolescents 12 through 15 years of age. The FDA previously amended the EUA for administration in individuals 16 years of age and older.  All ages are subject to change. 
  •  Vaccine Finder allows you to search by vaccine type and location in Colorado. 

Who Shouldn't Get a Vaccine?

The vaccines have received Emergency Use Authorization (EUA) by the FDA and are considered highly safe and effective at preventing COVID-19 infections. Most people 12 years and older (for Pfizer) and 18 and older (for Moderna and Johnson and Johnson vaccines) are able to safely receive the vaccine, but please contact your doctor if you: 

    • Are currently in isolation or have a fever 24 hours after the end of isolation with no improvement in symptoms 
    • Have been treated for COVID-19 within the last 90 days with monoclonal antibodies or convalescent plasma
    • Had a severe allergic reaction after a previous dose of this vaccine
    • Have had a severe allergic reaction to any ingredient of this vaccine.

A Compilation of Vaccine Resources and Information  

The development and distribution a COVID-19 vaccine will require a large scale effort by state, local, and private sector partners. The first phase will focus on frontline health care workers, first responders, and our most vulnerable populations living in long-term care facilities. Until the vaccine is widely available to the general public, we all need to continue to follow critical public health protocols. Please wear a mask in public, maintain at least 6 feet of distance from others, avoid gatherings, wash your hands often, and stay home when you are sick. 

Background: 

Scientists have developed several possible vaccines to provide immunity to COVID-19.  Once a company develops a vaccine, it must go through a rigorous scientific testing process before it can be submitted to the Food and Drug Administration (FDA). The FDA independently reviews the information from these tests to make sure the vaccine is safe and works well, and then decides whether the vaccine can be licensed and made available to the public. The pharmaceutical companies Pfizer and Moderna have applied for an Emergency Use Authorization with the Food and Drug Administration (FDA). The FDA authorized the Pfizer vaccine for emergency use on December 11, and Colorado received the vaccine beginning December 14. Moderna vaccine is expected to arrive in Colorado the week of December 22. 

Safety and Effectiveness: 

The companies report that both vaccines are around 95% effective. While the development process was efficient, the world's leading vaccine companies, in conjunction with the FDA and independent scientists, have used the same rigorous structure to develop these vaccines as has been used for all other drug and vaccine development. These involve multiple studies or “phased trials” across many months with larger and larger groups of people to ensure that the vaccine is both safe and effective for the general public. Tens of thousands of individuals across the US and the world have volunteered and helped provide this important information.

About mRNA-1273, Moderna’s Vaccine Against COVID-19:

The Moderna vaccine, or mRNA-1273 works by helping the immune system produce effective antibodies against the SARS-CoV-2 virus so that, in case of infection, the virus does not cause illness. The vaccine cannot cause infection or make someone sick with COVID-19. Learn more about the Moderna vaccine safety and effectiveness by the FDA here

Two-Dose Vaccines: 

Both mRNA vaccines require two injections, given either 21 or 28 days apart. The first dose primes the immune system and the second dose helps boost the immune system even further to help provide better protection against the coronavirus. Two shots spaced apart are necessary as the Pfizer vaccine has been shown to be 95% effective after an individual receives 2 doses, however, only 52% effective if an individual receives just a single dose.